Page 77 - Current Reports News Today

The ODP Corporation , a leading provider of products, services and technology solutions to businesses and consumers, noted the open letter sent to the Company by AREX Capital Management on December...

Cell MedX Corp. , a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, announces that Mr. Dwayne...

Proxy Statement Pursuant to Section 14 of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a...

SJW Group attained the highest ranking of any water utility included in the index. ...

Golden, Colorado & Nashville, Tennessee, Dec. 18, 2023 -- Theralink Technologies , a precision oncology company with an exclusively licensed commercial RPPA technology platform, is excited to...

Enrollment in the Company’s Phase II study using XProTM to treat patients with Alzheimer’s Disease with neuroinflammation is accelerating in sites outside the US and the Company is maintaining its

Bluebird bio, Inc. today announced that it has commenced an underwritten public offering of $150,000,000 of shares of its common stock. bluebird also intends to grant the underwriters a 30-day...

Patricia Ferrari and Carol Flaton to Enhance the Boards and Managements Ongoing Strategic, Operational and Financing Initiatives MIAMI, Dec. 18, 2023 /PRNewswire/ -- Cano Health, Inc. , a leading...

PRINCETON, N.J.--(BUSINESS WIRE)--$BMY #CRC--Bristol Myers Squibb (NYSE: BMY) today announced that the Phase 3 RELATIVITY-123 trial evaluating the fixed-dose combination of nivolumab and relatlimab for the treatment of microsatellite stable (MSS) metastatic colorectal cancer (mCRC) patients whose disease has progres...

CAMBRIDGE, Mass., Dec. 14, 2023 (GLOBE NEWSWIRE) --  Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a life science company...